Study of Pegilodecakin (LY3500518) With Pembrolizumab Compared to Pembrolizumab Alone First-line Tx in Participants With Metastatic Non-Small Cell Lung Cancer

Name: Study of Pegilodecakin (LY3500518) With Pembrolizumab Compared to Pembrolizumab Alone First-line Tx in Participants With Metastatic Non-Small Cell Lung Cancer
License: Public Domain

Eli Lilly and Company

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

non small cell lung cancer

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 303650
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.